Principal-component analysis for assessment of population stratification in mitochondrial medical genetics
- PMID: 20537299
- PMCID: PMC3032075
- DOI: 10.1016/j.ajhg.2010.05.005
Principal-component analysis for assessment of population stratification in mitochondrial medical genetics
Abstract
Although inherited mitochondrial genetic variation can cause human disease, no validated methods exist for control of confounding due to mitochondrial population stratification (PS). We sought to identify a reliable method for PS assessment in mitochondrial medical genetics. We analyzed mitochondrial SNP data from 1513 European American individuals concomitantly genotyped with the use of a previously validated panel of 144 mitochondrial markers as well as the Affymetrix 6.0 (n = 432), Illumina 610-Quad (n = 458), or Illumina 660 (n = 623) platforms. Additional analyses were performed in 938 participants in the Human Genome Diversity Panel (HGDP) (Illumina 650). We compared the following methods for controlling for PS: haplogroup-stratified analyses, mitochondrial principal-component analysis (PCA), and combined autosomal-mitochondrial PCA. We computed mitochondrial genomic inflation factors (mtGIFs) and test statistics for simulated case-control and continuous phenotypes (10,000 simulations each) with varying degrees of correlation with mitochondrial ancestry. Results were then compared across adjustment methods. We also calculated power for discovery of true associations under each method, using a simulation approach. Mitochondrial PCA recapitulated haplogroup information, but haplogroup-stratified analyses were inferior to mitochondrial PCA in controlling for PS. Correlation between nuclear and mitochondrial principal components (PCs) was very limited. Adjustment for nuclear PCs had no effect on mitochondrial analysis of simulated phenotypes. Mitochondrial PCA performed with the use of data from commercially available genome-wide arrays correlated strongly with PCA performed with the use of an exhaustive mitochondrial marker panel. Finally, we demonstrate, through simulation, no loss in power for detection of true associations with the use of mitochondrial PCA.
Copyright 2010 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- Hudson G., Mowbray C., Elson J.L., Jacob A., Boggild M., Torroni A., Chinnery P.F. Does mitochondrial DNA predispose to neuromyelitis optica (Devic's disease)? Brain. 2008;131:e93. - PubMed
-
- Poyton R.O., Ball K.A., Castello P.R. Mitochondrial generation of free radicals and hypoxic signaling. Trends Endocrinol. Metab. 2009;20:332–340. - PubMed
-
- Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007;39:44–84. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- Z01 AG000954/ImNIH/Intramural NIH HHS/United States
- K23 NS042720/NS/NINDS NIH HHS/United States
- R01 NS052585/NS/NINDS NIH HHS/United States
- P50 NS051343/NS/NINDS NIH HHS/United States
- R01 NS059727/NS/NINDS NIH HHS/United States
- 5K23NS042720/NS/NINDS NIH HHS/United States
- R01NS059727/NS/NINDS NIH HHS/United States
- U54 RR020278/RR/NCRR NIH HHS/United States
- Z01 AG000954-06/AG/NIA NIH HHS/United States
- K23 NS064052/NS/NINDS NIH HHS/United States
- R01NS052585/NS/NINDS NIH HHS/United States
- 5P50NS051343/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
